Reactivity of anti‐SARS‐CoV ‐2 antibodies in Serbian voluntary blood donors
Transfusion Medicine · 2024
DOI: 10.1111/tme.13034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transfusion Medicine, 2024. Verfasst von Milomir Radoslav Bezanovic und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department for Blood Collection, Testing and Production of Blood Products, Blood Transfusion Institute of Vojvodina, Novi Sad, Serbia. Hauptthemen laut MEDLINE: Blood Donors, COVID-19, Antibodies, Viral, SARS-CoV-2. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 54 Literaturangaben.
Abstract (Originalsprache)
Background
The COVID‐19 pandemic has major implications on the entire blood supply system worldwide. Seroepidemiological studies are certainly necessary for better understanding the global burden that the COVID‐19 pandemic represents.
Objectives
In this study, we analysed the association between demographic factors, COVID‐19 severity, vaccination status and the reactivity of anti‐SARS‐CoV‐2 IgG antibodies in Serbian blood donors. Materials and Methods In a prospective study, demographic data and data related to previous SARS‐CoV‐2 infection, COVID‐19 severity and vaccination status among whole blood donors were analysed, from February 10 to August 10, 2022, at the Blood Transfusion Institute of Vojvodina, Serbia. The detection and determination of the level of anti‐SARS‐CoV‐2 IgG antibodies were performed using LIAISON® SARS‐CoV‐2 TrimericS IgG immunoassay.
Results
A total of 1190 blood donors were included, 24.5% were female and 75.5% were male while their average age was 41 years. Anti‐SARS‐CoV‐2 antibody values ranged from 2.40 to 3120 BAU/ml with a mean value of 1354.56 BAU/ml. Statistical analysis showed that COVID‐19 severity and vaccination status are linked with reactivity of anti‐SARS‐CoV‐2 antibodies, while gender and age of voluntary blood donors are not related to the values of anti‐SARS‐CoV‐2 antibodies.
Conclusion
The values of anti‐SARS‐CoV‐2 antibodies in voluntary blood donors in Serbia are kept relatively high, especially in blood donors who have overcome the severe COVID‐19, as well as in donors who have been vaccinated against COVID‐19. Further SARS‐CoV‐2 seroprevalence studies in our country are certainly still necessary so global strategies to fight against COVID‐19 would be adequately evaluated.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department for Blood Collection, Testing and Production of Blood Products, Blood Transfusion Institute of Vojvodina, Novi Sad, Serbia.
- Department of Transfusiology, Faculty of Medicine in Novi Sad, University of Novi Sad, Novi Sad, Serbia.
- Clinic for Orthopedic Surgery and Traumatology, Clinical Center of Vojvodina, Novi Sad, Serbia.
- Department of Environmental Engineering and Occupational Health and Safety, Faculty of Technical Sciences in Novi Sad, University of Novi Sad, Novi Sad, Serbia.
ORCID-Profile: Milomir Radoslav Bezanovic, Zorana Budakov Obradovic, Nevenka Bujandric, Neda Kocic, Mirjana Krga Milanovic, Milan Majkic, Boris Obrovski, Jasmina Grujic
Zitieren
APA
Bezanovic, M. R., Obradovic, Z. B., Bujandric, N., Kocic, N., Milanovic, M. K., Majkic, M., Obrovski, B., & Grujic, J. (2024). Reactivity of anti‐SARS‐CoV ‐2 antibodies in Serbian voluntary blood donors. Transfusion Medicine. https://doi.org/10.1111/tme.13034
Vancouver
Bezanovic MR, Obradovic ZB, Bujandric N, Kocic N, Milanovic MK, Majkic M, et al. Reactivity of anti‐SARS‐CoV ‐2 antibodies in Serbian voluntary blood donors. Transfusion Medicine. 2024. doi:10.1111/tme.13034
BibTeX
@article{Bezanovic2024,
author = {Bezanovic, Milomir Radoslav and Obradovic, Zorana Budakov and Bujandric, Nevenka and Kocic, Neda and Milanovic, Mirjana Krga and Majkic, Milan and Obrovski, Boris and Grujic, Jasmina},
title = {Reactivity of anti‐SARS‐CoV ‐2 antibodies in Serbian voluntary blood donors},
journal = {Transfusion Medicine},
year = {2024},
doi = {10.1111/tme.13034}
}
EUVIMED